RxDoctor Payments Data

Bryan Sofen, MD

MOHS-Micrographic Surgery · Royal Oak, MINPI 1043452139

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (48.6%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 35 manufacturers reported payments, led by Amgen at 54.0% of the total. Reporting peaked in 2019 at $14,722 and has fallen 94.8% since, to $767 in 2025. Among mohs-micrographic surgery clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$35,453in general payments, 2019–2025

Across 297 payments — averaging $119.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$19K
  • Bristol Myers Squibb$10K
  • Novartis$644
  • Sun Pharmaceutical Industries Inc.$500
  • AbbVie$478
  • Biofrontera Inc.$472
  • plus $4K from 29 others

What the payments were for

  • Consulting fees$8,39124%
  • Speaking & faculty fees$17,23849%
  • Travel & lodging$2,2386%
  • Food & beverage$7,40621%
  • Education$1811%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$35,453 in reported general payments places this provider in the 95th percentile of 30 mohs-micrographic surgery providers in Michigan.

See all mohs-micrographic surgery providers in Michigan

Medicare billing

Part B allowed, 2024
$1,172,134
Medicare patients
213
Services billed
1,963

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin203$1,397
Isotretinoin12$1,261
Clobetasol Propionate30$1,038
Cephalexin49$738
Triamcinolone Acetonide44$629
Ketoconazole21$439
Doxycycline Hyclate11$173
Spironolactone11$68
Prednisone17$52

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Royal Oak

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →